Medicine Man Technologies, Inc. Quarterly Debt-to-equity in % from Q2 2016 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Medicine Man Technologies, Inc. quarterly Debt-to-equity history and growth rate from Q2 2016 to Q4 2023.
  • Medicine Man Technologies, Inc. Debt-to-equity for the quarter ending December 31, 2023 was 160 %, a 25.6% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 160 +32.5 +25.6% Dec 31, 2023
Q3 2023 147 +27.4 +22.9% Sep 30, 2023
Q2 2023 134 +22.7 +20.3% Jun 30, 2023
Q1 2023 122 +18.4 +17.7% Mar 31, 2023
Q4 2022 127 +48.5 +61.7% Dec 31, 2022
Q3 2022 120 +54.6 +83.4% Sep 30, 2022
Q2 2022 112 +49.8 +80.2% Jun 30, 2022
Q1 2022 104 +46.9 +82.5% Mar 31, 2022
Q4 2021 78.6 +39.2 +99.1% Dec 31, 2021
Q3 2021 65.4 +42.2 +181% Sep 30, 2021
Q2 2021 62 +38.3 +162% Jun 30, 2021
Q1 2021 56.8 +30.5 +116% Mar 31, 2021
Q4 2020 39.5 +11 +38.7% Dec 31, 2020
Q3 2020 23.3 -2.81 -10.8% Sep 30, 2020
Q2 2020 23.7 +6.36 +36.7% Jun 30, 2020
Q1 2020 26.4 +20.4 +338% Mar 31, 2020
Q4 2019 28.5 +25.9 +992% Dec 31, 2019
Q3 2019 26.1 +24.5 +1614% Sep 30, 2019
Q2 2019 17.3 +13.9 +403% Jun 30, 2019
Q1 2019 6.01 +0.22 +3.8% Mar 31, 2019
Q4 2018 2.61 -8.77 -77.1% Dec 31, 2018
Q3 2018 1.52 -21.7 -93.5% Sep 30, 2018
Q2 2018 3.45 -43.6 -92.7% Jun 30, 2018
Q1 2018 5.8 -1.25K -99.5% Mar 31, 2018
Q4 2017 11.4 -212 -94.9% Dec 31, 2017
Q3 2017 23.2 +5.92 +34.2% Sep 30, 2017
Q2 2017 47.1 +41.2 +709% Jun 30, 2017
Q1 2017 1.25K Mar 31, 2017
Q4 2016 223 Dec 31, 2016
Q3 2016 17.3 Sep 30, 2016
Q2 2016 5.81* Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.